Andecaliximab With mFOLFOX6 as First Line Treatment for Advanced Gastric or Gastroesophageal Junction Adenocarcinoma
Clinical trial NCT02545504 · COMPLETED
Trial details
- NCT number
- NCT02545504
- Sponsor
- Gilead Sciences
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2015-10-13
- Primary completion
- 2019-05-15
- Enrollment
- 432
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.